0000805928-21-000175.txt : 20211222
0000805928-21-000175.hdr.sgml : 20211222
20211222160619
ACCESSION NUMBER: 0000805928-21-000175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211220
FILED AS OF DATE: 20211222
DATE AS OF CHANGE: 20211222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedman Mark Louis
CENTRAL INDEX KEY: 0001531023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 211513288
MAIL ADDRESS:
STREET 1: AXOGEN, INC
STREET 2: 13859 PROGRESS BLVD SUITE 100
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_164020715735933.xml
FORM 4
X0306
4
2021-12-20
0
0000805928
Axogen, Inc.
AXGN
0001531023
Friedman Mark Louis
13631 PROGRESS BOULEVARD
SUITE 400
ALACHUA
FL
32615
0
1
0
0
VP Regulatory Affairs & Policy
Common Stock
2021-12-20
4
M
0
375
0
A
16683
D
Common Stock
2021-12-20
4
F
0
95
9.24
D
16588
D
Restricted Stock Units
0.0
2021-12-20
4
M
0
375
0
D
2021-12-20
2021-12-20
Common Stock
375.0
0
D
This reflects the number of restricted stock units that became vested as of December 18, 2021.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
/s/Mark Friedman
2021-12-22